Next Article in Journal
Anticancer, Cardio-Protective and Anti-Inflammatory Potential of Natural-Sources-Derived Phenolic Acids
Previous Article in Journal
Phytochemistry Meets Geochemistry—Blumenol C Sulfate: A New Megastigmane Sulfate from Palicourea luxurians (Rubiaceae: Palicoureeae)
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Design and Screening of New Lead Compounds for Autism Based on QSAR Model and Molecular Docking Studies

1
School of Public Health, Qingdao University, Qingdao 266071, China
2
School of Basic Medicine, Ningxia Medical University, Yinchuan 750004, China
3
New Fibrous Materials and Modern Textile State Key Laboratory, Qingdao University, Qingdao 266071, China
4
Quantum Institute, Queenland Montessori College, Surrey, BC V3Z 0T3, Canada
5
Department of Chemistry, Lanzhou University, Lanzhou 730000, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Molecules 2022, 27(21), 7285; https://doi.org/10.3390/molecules27217285
Submission received: 4 September 2022 / Revised: 13 October 2022 / Accepted: 24 October 2022 / Published: 26 October 2022

Abstract

:
The purpose of the present study aims to develop a satisfactory model for predicting pro-social and pro-cognitive effects on azinesulfonamides of cyclic amine derivatives as potential antipsychotics. The three dimensional-quantitative structure affinity relationship (3D-QSAR) study was performed on a series of azinesulfonamides of cyclic amine derivative using comparative molecular similarity indices analysis (CoMSIA). The best statistical model of CoMSIA q2, r2, SEE and F values are 0.664, 0.973, 0.087, and 82.344, respectively. Based on the model contour maps and the highest activity structure of the 43rd compound, serial new structures were designed and the 43k1 compound was selected as the best structure. The dock results showed a good binding of 43k1 with the protein (PDB ID: 6A93). The QSAR model analysis of the contour maps can help us to provide guidelines for finding novel potential antipsychotics.

1. Introduction

Autism is a kind of syndrome caused by abnormal neuropsychological function, which leads to serious problems in communication, social communication, and behavior. Researchers have defined autism as a neuro-developmental disorder that autism affects the ability to interact and communicate with other people [1].
At present, autism is a common psychological disease in children [1]. According to a 2016 report by the National Center for Health Statistics, the prevalence of autism among children in the United States is 2.2%, while the prevalence of autism in China is about 1 percent. Among them, there are about 20% of new cases per year and most of them are children [2]. Autism can cause a life quality decrease, gastrointestinal symptoms, sleep problems, and social problems [3]. And it will affect the child’s development and life in the future. Drugs are the main way to treat this disease. Nowadays, it has been found that most antipsychotic drugs can bind to dopamine D2 receptors (D2Rs) in the mesolimbic and nigrostriatal brain areas [4]. Although these drugs can alleviate symptoms, they also bring forth side effects, such as induction of extrapyramidal symptoms (EPS) and hyperprolactinemia. Therefore, second-generation antipsychotics with a high affinity for various serotonin receptors were found. Since the 5-HT2A/D2 has higher receptor affinity, 5-HT1AR activation contributes to the antidepressant and anti-anxiety properties of antipsychotics. The blockade of 5-HT6Rs has a novel mechanism to treat cognitive impairment in schizophrenia [5]. In this regard, antagonists and inverse agonists of 5-HT6R display precognitive actions in preclinical and clinical settings [6]. Preclinical data demonstrate that the 5-HT7R antagonist SB-269970 exerts pro-social effects [7]. To find novel and effective structures, artificial intelligence can be used for new drug findings.
The Quantitative Structure-Affinity Relationship (QSAR) method has been used for new drug finding and designing. There are a few studies of QSAR has been applied to find antipsychotics. Benzamide antipsychotics were classified as second-generation antipsychotics, the QSAR model showed the structures of 5-sulfonyl on the benzene ring and N-ethyl-2-aminomethyl pyrrolidine played a role in antipsychotic activity [8,9]. The biological activities of psychiatric drugs were evaluated by QSAR models [10]. This study found that 2-trifluoromethyl-phenothiazine dihydrochloride and 2-trifluoromethyl-phenothiazine hydrochloride derivatives exhibited an influence on the frequency of necrotic effect on lymphocytes in comparison with fluphenazine [11]. Based on the works, the QSAR model can aid to understand the mechanism of compound interaction with targets, the main important structures that can influence the activities. At present, there are no other QSAR studies for azinesulfonamides of cyclic amine derivatives.
Higher activity and fewer side effects drugs are needed in clinics, however, traditional drugs finding are time and cost-consuming. At present, artificial intelligence is used in nearly most drug development, such as in structure design, bioinformatics, property prediction, and so on. Therefore, computational methods have been extensively used for drug discovery and development.
QSAR method is a mathematical relationship linking chemical structure and pharmacological affinity or other properties. QSAR has been applied widely to drug discovery which can predict affinity-related characteristics of drug candidates [12,13,14]. The QSAR techniques will be used in a vast area of functional chemicals such as pharmaceuticals, agrochemicals, flavor, perfumeries, analytical reagents, solvents, and household chemicals. It also can be applied to the chemicals of health benefits, the chemicals responsible for environmental hazards, and the chemicals in the industrial/laboratory processes [15,16]. In this study, CoMFA and comparative molecular similarity indices analysis (CoMSIA) were used to build the QSAR model. However, CoMFA only has stereoscopic and electrostatic force fields. CoMSIA provides five force fields, including stereoscopic and electrostatic force fields, so we only used the CoMSIA technique in our work. CoMSIA as one of the QSAR methods was applied to develop a satisfactory model based on azinesulfonamides of cyclic amine derivatives as potential antipsychotics with pro-social and pro-cognitive effects. Meanwhile, the developed model with visualize structural information was used to design more structures. CoMSIA can provide stereoscopic, electrostatic, hydrophobic, hydrogen bond donors and hydrogen bond recipients force fields. The 43rd compound has the best Ki value, so it was chosen as the template molecule. We can modify 43rd structure at the five force fields position. Lots of new structures will be found. Then all the new compounds will have been predicted pKi values by our QSAR model. The lowest Ki value structure is the best one which was selected to do binding with protein. According to the QSAR model, the new structure 43k1 contained the hydrophobic group benzene. And the acceptor group F was used to modify the structure, two H-bonds were found between F and residues ASP-155 and SER-159. Therefore, the 43k1 compound has a good binding with protein (PDB code: 6A93).

2. Results and Discussion

2.1. Alignment Commune Statistics

It is important to select an appropriate structural alignment of the compounds in 3D-QSAR analysis. There are two different alignment techniques, one is ligand-based alignment and the other is receptor-based alignment. In this study, the former was adopted (Figure 1). In this approach, all compounds were aligned to the most potent compound 43 in the Sybyl package because it demonstrated potential anti-autism activity with pKi of 5 nM and provided a new scaffold for drug development and the alignment moiety here was the common structure of each molecule (Figure 1).
Stereoscopic field, static electricity, hydrophobic, hydrogen bond donors, and hydrogen bond recipients were applied to analyze the CoMSIA model. These five molecular fields are the best statistical results of the CoMSIA model. Based on five fields and 15 different models were generated. Among them, 5 field parameters were used in model 15. It was the best model with superiority in all aspects of analysis. The 15th model is the best one. Of the 15th model, the q2, r2, SEE, and F values were 0.664, 0.973, 0.087, and 82.344, respectively. The hydrogen bond donor has the maximum contribution in this model. At the same time, CoMFA analysis also was finished, r2, q2, F values, and SEE were 0.973, 0.629, 82.352, and 0.087, respectively.

2.2. Validation of CoMSIA Model

Bootstrapping analysis for 100 runs and Y-randomization performed 10 times were applied to measure the bias of the original calculations and evaluate the robustness and the statistical significance of the derived models. In the former, an average r2 boot value of 0.986 (higher than r2) and a SEE boot value of 0.062 (lower than SEE) were calculated. In the latter, the q2 (0.558 to 0.721) and the R p 2 value of 0.537 demonstrated that the derived model was not affected by chance correlations. The external predictive ability of the CoMSIA model was assessed by predicting the affinity of the test set. The statistic parameters suggested that the derived model had a good predictive ability. The experimental predicted activities and the residual values were listed in Table 1. Figure 2 showed a good relationship between predicted pKi values and experimental values. From Table 1, we can find that the 60th compound has the groups of 5-Isoquinolyl benzo[d]isoxazole and enant R, the 72nd and 53rd compounds have the structures of 4-Isoquinolyl benzo[d]isothiazole and enant S. To our knowledge, chemical structure determines chemical properties. QSAR model shows the relationship of structure with properties. Therefore, for the different structural features of the 60th, 72nd, and 53rd compounds compared with the others, the predicted pKi values have a larger variation (Figure 2).

2.3. CoMSIA Map

The CoMSIA model provides us with important information, which can show the relationship between the structures and biological affinity of compounds. We took the most affinity molecule 43rd as the reference molecule shown in Figure 3, and the three-dimensional color outline was constructed according to the best CoMSIA model. With the outline diagram, if the corresponding groups of the compounds were changed, the affinity of the compounds will change with the structure changing. Meanwhile, the contour maps, constructed the model by the field type StDev⁄Coeff (the standard deviation and the coefficient) with default values of 80% favored and 20% disfavored contributions. The contour maps help to identify the important regions where variation in the steric, electrostatic, hydrophobic, hydrogen bond donor, and acceptor fields around the compound [17].
The three-dimensional profile is shown in Figure 3A. The group of 2,3-dihydrobenzo[b][1,4]dioxine of 43 compounds falls into a sterically favorable green contour, suggesting that the steric bulk in this position is crucial for structure affinity relationships. The co-localization of the 2,3-dihydrobenzo[b][1,4]dioxine group within the green contour maps suggests the importance of steric bulk at this position. The two green contour maps placed onto the meta and para positions of the ring indicate that steric bulk at these positions is important for affinity. These two green contour maps were found to be colocalized with the blue contour map indicating a favorable effect of the steric bulk with high electron density containing groups. The small green contour maps around the ring suggest the sterically favorable region. Yellow contour map indicates that occupancy of these sterically unfavorable maps which have a negative effect on affinity. Figure 3B shows the electrostatic field diagram, in which the blue and red areas represent the positive and negative favorable areas, respectively. Figure 3B reveals the electrostatic contour maps for the CoMSIA analysis of affinity. The large blue contour maps indicate that the electropositive potential in these rings increases affinity. The electrostatic potential is more positive and thereby leads to compounds with enhanced affinity potencies. The red contour maps around the positions of the ring indicate that electronegative groups at these positions would decrease affinity. Compound 43 with 2,3-dihydrobenzo[b][1,4]dioxine substituent is more corresponding (electropositive) substituent.
Several small red contour maps around the ring suggest the importance of electronegative groups. The CoMSIA electrostatic contour map for affinity is depicted in Figure 3B. The small and large blue contour maps were located on the para positions. This finding indicated that the simultaneous presence of electron-withdrawing groups at the para positions of the 2,3-dihydrobenzo[b][1,4]dioxine was essential for potent affinity. Figure 3C showed the hydrophobic profile. Adding hydrophobic groups near the yellow profile is beneficial to increase the affinity of the compound, while the white profile indicated that reducing hydrophobic groups could increase the affinity of the compound. Otherwise, it will reduce the affinity of the compound. The profiles of hydrogen donors and hydrogen acceptors were shown in Figure 3D,E. The cyan and purple outlines provide useful sites for hydrogen donors. Magenta and red outlines indicated the favorable and unfavorable regions of hydrogen receptors for the affinity of compounds, respectively. Based on the map, new structures were designed, and a good activity for antipsychotic inhibitors has been screed.

2.4. Topomer CoMFA Analysis

Before submitting the job for Topomer CoMFA analysis, each of the training set structures was broken into two sets of fragments. The two Topomer CoMFA model was obtained by changing the segmentation methods by using a training set. The q2 and r2 of the were 0.658 and 0.916. For a reliable predictive model, the q2 should be >0.5, the models are also obtained from both CoMFA and CoMISA, the q2 and r2 of the CoMFA model were 0.629 and 0.973, the q2 and r2 of CoMISA model were 0.664 and 0.973. Because Topomer CoMFA and CoMFA analysis results of q2 were lower than the CoMISA model. Especially topomer CoMFA and CoMFA only provide stereoscopic and electrostatic force fields, which were insufficient to analyze the design of new structures. Therefore, in this work, we only used the CoMISA model for new compound findings.

2.5. Design of New Compounds and Prediction of Their Activity

3D-QSAR has been widely used in the design and prediction of new compounds. Based on the above analysis, we obtained the main factors affecting affinity and added the corresponding groups based on the tips in each section of the contour map. From Table 2, the 15th model statistical parameters of q2, r2, F value, and SEE were 0.664, 0.973, 82.344, and 0.087 respectively. For the higher q2 and r2 values and lower SEE values, this model is the best one in our study. Since the structure of 43rd has the lowest Ki value, 43rd structure was modified according to the five force fields position of the 15th model. Several serials of new structures can be constructed. All new compounds were predicted pKi values by our QSAR model. Free combination, compound modification, and optimization selected 12 molecules higher than compound 43 (43a–43k). The pKi predictions for these newly designed compounds using CoMSIA are shown in Table 3. The lowest Ki value structure of 43k1 is the best one which was selected to do binding with protein. The structure 43k1 contained the hydrophobic group benzene. H-bond acceptor group F also appeared in the 43k1 structure. The docking result showed that two H-bonds were found between F and residues ASP-155 and SER-159. Therefore, the 43k1 compound has a good binding with protein (PDB code: 6A93).

2.6. Molecular Docking Results

Molecular docking is a good demonstration of the interaction between small molecules and proteins. The affinity and total score of our modified 43k1 compound is an ideal level, so we analyzed the 43k1 compound. By docking, we found that the new compound formed a hydrogen bond with the ASP-155 residue of the protein, as well as a hydrogen bond with the SER-159 residue. At the same time, the hydrophobic formed surrounds 43k1, but the electrostatic or steric effects are not found. The result shows that the 43k1 compound has a good binding with the polymer proteins (Figure 4A,B). To validate the 43k1 compound, the 43rd compound was also docked with protein (PDB code: 6A93). The docking score was 8.203 (Figure 4C), while the 43k1 compound dock score was 11.337 (Table 3). The interaction of the compound with the protein is important. There is no H-bond between the 43rd compound and the protein. Therefore, the 43k1 compound dock result and affinity prediction are very satisfactory.

3. Materials and Methods

3.1. Dataset for Analyses

In our study, we cited literature that includes 51 structures. Among them, 6 drugs did not share a common skeleton with the other 45 structures, so we only selected 45 common skeleton compounds to develop the model [18]. The Ki values in the nanomole (nM) range were converted to the molar value range and then to its logarithmic scale (pKi = −logKi + 9) used for subsequent QSAR analysis to reduce the skewness of the data set. The structures and biological affinity values of 45 compounds were shown in Table 1. The dataset was randomly divided into a training set of 34 compounds and a test set of 11 compounds in the approximate ratio of 4:1. Training set was used for 3D-QSAR model construction and the test set was used for model validation of the established models as extra independent samples in the QSAR analysis.

3.2. Optimization of Structures

We built all the selected compounds using ChemDraw. We then put the constructed compounds into Sybyl software (SYBYL-X-2.1.1) for optimization and molecular modeling. Tripos force field and Powell gradient algorithm with a convergence criterion of 0.05 kcal/mol were used to carry out structural energy minimization and the minimized structures were used for CoMSIA as the initial conformation.

3.3. Conformational Sampling and Alignment

In 3D-QSAR, compound alignment is based on both mating and subject alignment. In this study, we chose a mating-based alignment. We selected the 43rd compound as a template molecule to align all compounds to because the 43rd compound has a high affinity with 5-HT1A in all compounds.

3.4. CoMSIA Model Study

CoMSIA in Sybyl was used for the model study. CoMSIA is one of the most reliable tools for studying 3D-QSAR because of its feature in avoiding singularities at the atomic positions arising from the Lennard-Jones and dramatic changes of coulomb potential fields. The CoMSIA descriptors were calculated by a 3D cubic lattice with a grid spacing of 2 and extending 4 units beyond the aligned molecules in all directions. The partial least squares (PLS) analysis was used to correlate the CoMSIA fields to the pKi values in order to generate a statistically significant 3D-QSAR model performed in two stages. Firstly, a leave-one-out (LOO) cross-validation analysis was carried out to determine the optimum number of components (ONC) and cross-validated correlation coefficient (q2). Then, non-cross-validation analysis was performed using the ONC to generate the final PLS regression models for CoMSIA. The non-cross-validation results were evaluated by several statistical parameters including the non-cross-validated correlation coefficient (r2), the standard error of estimate (SEE), and the F value. To further evaluate the robustness and the statistical significance of the derived, the validation model must be finished.
The CoMSIA model was assessed by predicting the affinity of 11 compounds of the test set and the external predictive correlation coefficient R e x t 2 was computed using the following equation:
R e x t 2 = 1 P R E S S / S D
The SD is the sum of the squared deviations between the biological affinity of compounds in the test set and the mean biological affinity of training molecules, and the predictive of squares (PRESS) denotes the sum of square deviation between the predictive and experimental activities of the test molecules. In addition, R m ( o v e r a l l ) 2 was introduced and computed by the following equation to further validate the predictive ability of the model:
R m ( o v e r a l l ) 2 = R 2 ( 1 R 2 R 0 2 )
In the equation, R 2 and R 0 2 are squared correlation coefficients between the observed and predicted activities of the test set with and without intercept, respectively. The parameter determines the extent of the range of predicted affinity values for the whole dataset and the observed affinity. Those values above including R e x t 2 and R m ( o v e r a l l ) 2 should be higher than 0.5 for a satisfactory model [19,20].

3.5. Topomer CoMFA

Topomer CoMFA is a rapid fragment-based three-dimensional quantitative structure-activity relationship (3D-QSAR) method. Unlike traditional CoMFA, the Topomer CoMFA does not require subjective alignment of 3D ligand conformers and uses automatic alignment rules, so analysis is faster. The steps of the Topomer CoMFA are as follows:
(1)
Split the 3D molecular structure into fragments containing common features, open valence bonds, or linkages.
(2)
Align each segment based on overlapping parts to provide an absolute orientation of any segment.
(3)
Calculate the steric and electrostatic fields of the top-aligned segments.
(4)
Use PLS regression to build the model and the jackknife test to evaluate the model.
The r2 and q2 were used to evaluate the Topomer CoMFA models. The cutoff values of r2 and q2 are 0.8 and 0.5, respectively. The optimum model was determined by the highest q2, and the validity of the model depends on the r2 value.

3.6. Molecular Docking

Through molecular docking, we could study the molecular interaction mechanism and the appropriate binding mode. Molecular docking was carried out in the software Sybyl. We searched the RSCB protein database (PDB code: 6A93) and found that the structure of the ligand in 6A93 is similar to our selected 43rd compound. First, we modified the protein which was obtained from the PDB database. We introduced the protein into Sybyl software, removed the redundant water molecules, and extracted the ligands. Polar hydrogens and united atom Kollman charges were assigned for the receptor. Based on the automatic ligand model, the proposed binding affinity pocket can be created in the Sybyl package, where the ligand can be installed and potentially interact. The ProtoMol bloat and ProtoMol threshold parameters were set as default values of 0 and 0.5, respectively. Based on the PDB 6A93, this protein has the ligand, we created the activity pocket by the ligand structure interacting with the amino acid residue of the protein. We kept the top 10 conformations of each ligand and ranked them according to the total docking score. The best conformation of the ligand was analyzed by binding interaction.

4. Conclusions

In our study, molecular docking has been employed to identify a potential binding mode for these inhibitors at the crystal structure of the 5-HT2AR affinity site and the best-docked conformation of molecule 43 was used as a template for alignment. The CoMSIA model showed a higher q2 value of 0.646 and an r2 value of 0.973, this model has a good predictive ability. The CoMSIA model provides five fields of steric, electrostatic, hydrophobic, hydrogen donors, and hydrogen acceptors modification that can improve the affinity ability. Finally, a new structure of 43k1 was added to the hydrophobic group benzene based on Figure 3C. And Figure 3E, the acceptor group F was used to modify the structure, two H-bonds were found between F and residues ASP-155 and SER-159. The docking result and affinity prediction are very satisfactory. Therefore, the hydrophobic group and H-bond acceptor group are modified and led to azinesulfonamides of cyclic amine derivatives which can improve the affinity. Then the new structures also have good binding with protein. The better-predicted model plays a key role in drug design and screening.

Author Contributions

Conceptualization, K.M. and Y.C.; methodology, K.M. and Y.C.; software, K.M., Y.C. and H.Z.; validation, K.M., Y.C. and H.S.; formal analysis, K.M. and Y.C.; investigation, H.S.; resources, P.X.; data curation, H.S.; writing—original draft preparation, K.M., Y.C. and H.S.; writing—review and editing, Y.D., P.X. and H.S.; supervision, H.S.; project administration, H.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds are available from the authors.

References

  1. Tang, J. Investigation and countermeasure research on the status of autistic children in Tangshan city. Pop. Sci. 2019, 6, 64–138. [Google Scholar]
  2. Deng, M.; Huang, W.; Yan, T.R.; Guan, W.J. Current situation and discussions of education and rehabilitation of children with autism in China. Monogr. Study ASD 2014, 2, 37–42. [Google Scholar]
  3. Leader, G.; Barrett, A.; Ferrari, C.; Casburn, M.; Maher, L.; Naughton, K.; Arndt, S.; Mannion, A. Quality of life, gastrointestinal symptoms, sleep problems, social support, and social functioning in adults with autism spectrum disorder. Res. Dev. Disabil. 2021, 112, 103915. [Google Scholar] [CrossRef] [PubMed]
  4. Seeman, P.; Lee, T.; Chau-Wong, M.; Wong, K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 1976, 261, 717–719. [Google Scholar] [CrossRef] [PubMed]
  5. Friedman, J.I.; Carpenter, D.; Lu, J.; Fan, J.; Tang, C.Y.; White, L.; Parrella, M.; Bowler, S.; Elbaz, Z.; Flanagan, L. A pilot study of adjunctive atomoxetine treatment to second-generation antipsychotics for cognitive impairment in schizophrenia. J. Clin. Periodontol. 2008, 28, 59–63. [Google Scholar] [CrossRef] [PubMed]
  6. Nikiforuk, A. The procognitive effects of 5-ht6 receptor ligands in animal models of schizophrenia. Rev. Neurosci. 2014, 25, 367–382. [Google Scholar] [CrossRef] [PubMed]
  7. Canale, V.; Partyka, A.; Kurczab, R.; Krawczyk, M.; Kos, T.; Satała, G.; Kubica, B.; Jastrze˛bska-Wie˛sek, M.; Wesołowska, A.; Bojarski, A.J.; et al. Novel 5-HT7R antagonists, arylsulfonamide derivatives of (aryloxy)propyl piperidines: Add-on effect to the antidepressant activity of SSRI and DRI, and pro-cognitive profile. Bioorganic Med. Chem. 2017, 349, 889–903. [Google Scholar]
  8. Wang, Q.G.; Guo, J. The studies for classification and QSAR on the benzamide antipsychotics. Med. J. Chin. People’s Health 2011, 23, 2140–2141. [Google Scholar]
  9. Ma, J.; Zhang, H.; Zhang, X.; Lei, M. 3D-qsar studies of d3r antagonists and 5-ht1ar agonists-sciencedirect. J. Mol. Graph. Model 2019, 86, 132–141. [Google Scholar] [CrossRef] [PubMed]
  10. Duan, X.L.; Zhang, X.; Xu, B.L.; Wang, F.; Lei, M. Computational study and modified design of selective dopamine d3 receptor agonists. Chem. Biol. Drug Des. 2016, 88, 142–154. [Google Scholar] [CrossRef] [PubMed]
  11. Mernea, M.; Borcan, L.C.; Borcan, F.; Avram, S. Antipsychotics as psychosis drugs and neuroprotective promoters evaluated by chemical qsar-in silico and in vivo studies. Lett. Drug Des. Discov. 2016, 13, 269–275. [Google Scholar] [CrossRef]
  12. Chen, C.; Si, H.Z. QSAR models of Celecoxib analogues and derivatives as COX-2 inhibitor to predict their anti-inflammatory effect. Cancer Cell Res. 2022, 9, 827–835. [Google Scholar]
  13. Dearden, J.C. The history and development of quantitative structure-activity relationships (QSARs): Addendum. Int. J. Quant. Struct.-Prop. Relatsh. 2017, 2, 36–46. [Google Scholar] [CrossRef]
  14. Davis, J.D.; Debinski, D.M.; Danielson, B.J. Local and landscape effects on the butterfly community in fragmented midwest usa prairie habitats. Landsc. Ecol. 2017, 22, 1341–1354. [Google Scholar] [CrossRef]
  15. Roy, K.; Kar, S.; Das, R.N. Selected statistical methods in qsar-sciencedirect. Understanding the Basics of QSAR for Applications in Pharmaceutical Sciences and Risk Assessment; Academic press: Cambridge, MA, USA, 2015; pp. 191–229. [Google Scholar]
  16. Gadaleta, D.; Mangiatordi, G.F.; Catto, M.; Carotti, A.; Nicolotti, O. Applicability domain for qsar models: Where theory meets reality. Int. J. Solids. Struc. 2016, 1, 45–63. [Google Scholar] [CrossRef]
  17. Hornák, V.; Dvorský, R.; Sturdík, E. Receptor-ligand interaction and molecular modelling. Gen. Physiol. Biophys. 1999, 18, 231–248. [Google Scholar] [PubMed]
  18. Zajdel, P.; Kos, T.; Marciniec, K.; Satała, G.; Canale, V.; Kaminski, K.; Hołuj, M.; Lenda, T.; Koralewski, R.; Bednarski, M.; et al. Novel multi-target azinesulfonamides of cyclic amine derivatives as potential antipsychotics with pro-social and pro-cognitive effects. Eur. J. Med. Chem. 2018, 145, 790–804. [Google Scholar] [CrossRef] [PubMed]
  19. Qian, C.; Zheng, J.; Xiao, G.; Guo, J.; Sun, P. 3D-QSAR studies on thiazolidin-4-one S1P 1 receptor agonists by CoMFA and CoMSIA. Int. J. Mol. Sci. 2011, 12, 6502–6516. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Roy, P.P.; Paul, S.; Mitra, I.; Roy, K. On two novel parameters for validation of predictive qsar models. Molecules 2009, 14, 1660–1701. [Google Scholar]
Figure 1. The alignment of all compounds in the dataset, compound 43 was used as the template and the common substructure (shown in bold) for the alignment of all compounds.
Figure 1. The alignment of all compounds in the dataset, compound 43 was used as the template and the common substructure (shown in bold) for the alignment of all compounds.
Molecules 27 07285 g001
Figure 2. The predicted and the experimental pKi values (nM) of CoMSIA model.
Figure 2. The predicted and the experimental pKi values (nM) of CoMSIA model.
Molecules 27 07285 g002
Figure 3. Contour maps of CoMSIA model based on 43rd structure. (A) is the steric field diagram, favorable (green) and unfavorable (yellow). (B) is the electrostatic field diagram, positive (blue) and negative (red) areas. (C) is the hydrophobic profile diagram, favorable (yellow) and unfavorable (white). (D) is the hydrogen donors diagram, favorable (cyan). (E) is the hydrogen acceptor diagram, favorable (magenta) and adverse (red) hydrogen receptor areas.
Figure 3. Contour maps of CoMSIA model based on 43rd structure. (A) is the steric field diagram, favorable (green) and unfavorable (yellow). (B) is the electrostatic field diagram, positive (blue) and negative (red) areas. (C) is the hydrophobic profile diagram, favorable (yellow) and unfavorable (white). (D) is the hydrogen donors diagram, favorable (cyan). (E) is the hydrogen acceptor diagram, favorable (magenta) and adverse (red) hydrogen receptor areas.
Molecules 27 07285 g003
Figure 4. The molecular docking of newly designed compound 43k1 and compound 43 with protein 6A93. (A,B) are compound 43k1 interaction with protein, (C) is compound 43 with protein 6A93.
Figure 4. The molecular docking of newly designed compound 43k1 and compound 43 with protein 6A93. (A,B) are compound 43k1 interaction with protein, (C) is compound 43 with protein 6A93.
Molecules 27 07285 g004
Table 1. Structures of the azinesulfonamides of cyclic amine derivatives and Ki values.
Table 1. Structures of the azinesulfonamides of cyclic amine derivatives and Ki values.
Molecules 27 07285 i001
QEnantYArKi[nM] a
5-HT
385-QuinolylSNMolecules 27 07285 i00223
394-Isoquinolyl27
404-IsoquinolylR36
415-QuinolylSNMolecules 27 07285 i0036
424-Isoquinolyl6
43 *5-QuinolylR5
444-Isoquinolyl7
455-QuinolylSCMolecules 27 07285 i004146
464-Isoquinolyl66
475-QuinolylR91
484-Isoquinolyl147
495-QuinolylSCHMolecules 27 07285 i005147
504-Isoquinolyl111
51 *5-QuinolylR120
525-QuinolylSNMolecules 27 07285 i00625
53 *4-Isoquinolyl37
545-Isoquinolyl37
555-QuinolylR24
564-Isoquinolyl14
575-Isoquinolyl16
58 *5-QuinolylSNMolecules 27 07285 i007179
594-Isoquinolyl96
60 *5-IsoquinolylR86
615-QuinolylSNMolecules 27 07285 i00813
624-Isoquinolyl18
635-Isoquinolyl10
645-QuinolylR15
654-Isoquinolyl24
665-Isoquinolyl13
67 *5-QuinolylSNMolecules 27 07285 i00914
68 *4-Isoquinolyl8
69 *5-QuinolylR5
704-Isoquinolyl6
Molecules 27 07285 i010
Compd.QNEnantArKi[nM] a
715-Quinolyl0SMolecules 27 07285 i01154
72 *4-Isoquinolyl56
735-Quinolyl2R28
74 *4-Isoquinolyl24
755-Quinolyl3S48
764-Isoquinolyl50
775-Quinolyl0SMolecules 27 07285 i0129
78 *4-Isoquinolyl16
795-Quinolyl2R15
80 *4-Isoquinolyl12
815-Quinolyl3S12
824-Isoquinolyl8
a Ki values are the means of three independent binding experiments (SEM ≤ 21%), * test set.
Table 2. The parameters of the CoMSIA model and the statistical parameters of the best model (shown in bold).
Table 2. The parameters of the CoMSIA model and the statistical parameters of the best model (shown in bold).
ModelForce Fieldq2ONCr2F ValueSEE
1S,H and E0.72190.97395.4230.085
2S,A and E0.70590.97395.3610.085
3S,D and E0.63370.972129.2340.083
4S,D and H0.68180.971103.1020.087
5S,A and H0.70480.973111.4770.084
6S,A and D0.55880.972107.8590.085
7E,H and D0.68680.973111.1770.084
8E,H and A0.71380.973111.8610.083
9D,A and E0.59960.969141.4250.086
10S,E,H and D0.68180.973111.2410.084
11S,E,H and A0.71480.973111.8450.083
12S,E,D and A0.608100.97382.2040.087
13E,H,D and A0.66100.97382.3530.087
14S,H,D and A0.65690.97395.1700.085
15S,E,D,H and A0.664100.97382.3440.087
Table 3. The designed compounds and predicted pKi values.
Table 3. The designed compounds and predicted pKi values.
Molecules 27 07285 i013
CompoundR1R2R3pKiTotal score
43a1CH2CH3NH2NO29.6699.1321
43b2CH2CH3OHNO29.7358.0002
43c3CH2CH3FNO29.8567.7014
43d4CHCH2CH3NH2NO28.5647.3125
43e5CHCH2CH3OHNO28.6527.8187
43f6CHCH2CH3FNO28.77.5814
43g7C6H5NH2NO29.637.5474
43h8C6H5OHNO28.8637.6443
43i9C6H5FNO29.7557.0177
43j0NO2NH2C6H59.298.4763
43k1NO2OHC6H59.55411.3373
43l2NO2FC6H58.8439.5647
438.3018.2026
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Chen, Y.; Ma, K.; Xu, P.; Si, H.; Duan, Y.; Zhai, H. Design and Screening of New Lead Compounds for Autism Based on QSAR Model and Molecular Docking Studies. Molecules 2022, 27, 7285. https://doi.org/10.3390/molecules27217285

AMA Style

Chen Y, Ma K, Xu P, Si H, Duan Y, Zhai H. Design and Screening of New Lead Compounds for Autism Based on QSAR Model and Molecular Docking Studies. Molecules. 2022; 27(21):7285. https://doi.org/10.3390/molecules27217285

Chicago/Turabian Style

Chen, Yongjian, Kang Ma, Peilong Xu, Hongzong Si, Yunbo Duan, and Honglin Zhai. 2022. "Design and Screening of New Lead Compounds for Autism Based on QSAR Model and Molecular Docking Studies" Molecules 27, no. 21: 7285. https://doi.org/10.3390/molecules27217285

Article Metrics

Back to TopTop